Journals / KONURALP TIP DERGİSİ / 2020 / Cilt: 12 - Sayı: 1

Decreased Blood Loss with Systemic and Intraarticular Tranexamic Acid Administration after Total Knee Arthroplasty

Total Diz Artroplastisi Sonrası Sistemik ve İntraartiküler Traneksamik Asit Uygulaması ile Kan Kaybının Azalması

Pages
12–18
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mean blood loss from the drain inGroup 3 was significantly lower than that in Group 1 and Group 2 (p=0.001).Postoperative infection, DVT, and PE were not seen in any group.Conclusions: This study demonstrated that the use of intraarticular and intravenoustranexamic acid in primary unilateral TKA significantly reduced postoperative blood lossand consequently decreased the need for blood transfusion without an increase in adverseevents, particularly thromboembolic complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Perioperative bleeding during total knee arthroplasty (TKA) is a lastingproblem for surgeons.
📊
Key Findings & Data:Intravenous or intra-articular administration of tranexamic acid(TXA) can effectively stop bleeding, but there is still no uniform standard for the bestadministration and dosing.Methods: Between October 2017 and September 2019, ninety patients with unilateralprimary knee osteoarthritis requiring knee replacement were retrospectively evaluated andinvestigated in three groups according to the route of TXA administration: Group 1(n=30) intravenous (IV) injection, Group 2 (n=30) intra-articular injection (IAI), andGroup 3 (n = 30) combined IV and IAI.
💡
Conclusion & Impact:The mean blood loss from the drain inGroup 3 was significantly lower than that in Group 1 and Group 2 (p=0.001).Postoperative infection, DVT, and PE were not seen in any group.Conclusions: This study demonstrated that the use of intraarticular and intravenoustranexamic acid in primary unilateral TKA significantly reduced postoperative blood lossand consequently decreased the need for blood transfusion without an increase in adverseevents, particularly thromboembolic complications.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Perioperative bleeding during total knee arthroplasty (TKA) is a lastingproblem for surgeons. Intravenous or intra-articular administration of tranexamic acid(TXA) can effectively stop bleeding, but there is still no uniform standard for the bestadministration and dosing.Methods: Between October 2017 and September 2019, ninety patients with unilateralprimary knee osteoarthritis requiring knee replacement were retrospectively evaluated andinvestigated in three groups according to the route of TXA administration: Group 1(n=30) intravenous (IV) injection, Group 2 (n=30) intra-articular injection (IAI), andGroup 3 (n = 30) combined IV and IAI. Demographic characteristics, hematologicalindices, and the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE)were studied.Results: Of the patients included in the study, 86% were female (n=78), and 14% weremale (n=12). The gender distribution of the groups was homogeneous (p=0.749). Themean hemoglobin values of Group 2 were significantly lower than those of Group 1 andGroup 3 (p=0.002 and p=0.045, respectively). Less postoperative blood loss was observedin the group receiving combined IV and IA TXA. The mean blood loss from the drain inGroup 3 was significantly lower than that in Group 1 and Group 2 (p=0.001).Postoperative infection, DVT, and PE were not seen in any group.Conclusions: This study demonstrated that the use of intraarticular and intravenoustranexamic acid in primary unilateral TKA significantly reduced postoperative blood lossand consequently decreased the need for blood transfusion without an increase in adverseevents, particularly thromboembolic complications.

Özet

Amaç: Total diz artroplastisi (TDA) sırasında perioperatif kanama cerrahlar için devam eden bir problemdir. Traneksamik asidin (TXA) intravenöz veya intra-artiküler uygulanması kanamayı etkili bir şekilde durdurabilir, ancak en iyi uygulama ve doz yöntemi için hala bir standart yoktur. Gereç ve Yöntem: Ekim 2017 ile Eylül 2019 arasında diz replasmanı gerektiren tek taraflı primer diz osteoartriti olan 90 hasta retrospektif olarak değerlendirildi ve üç grup olarak incelendi. Grup 1 (n = 30) intravenöz(IV) , grup 2 (n = 30) intra-artiküler enjeksiyon (IAE) ve grup 3 (n = 30) ) TXA’nın hem IV hemde IA kombine enjeksiyon uygulanmıştır. Demografik özellikler, hematolojik indeksler, derin ven trombozu (DVT) ve pulmoner emboli( PE) görülme insidansı araştırıldı. Bulgular: Çalışmaya dahil edilen hastaların %86’sı kadın (n=78) ve %14’ü erkektir (n=12). Gruplara göre cinsiyet dağılımı homojendir (p=0,749). Grup 2’nin Hemoglobin(Hb) ortalamaları Grup 1 ve Grup 3’ün Hb ortalamalarından istatistiksel olarak anlamlı derecede düşük bulunmuş (p=0,002, p=0,045), Kombine IV ve IA TXA alan grupta postoperatif daha az kan kaybı gözlendi. Grup 3’ün Drenden Kan Kaybı ortalamaları Grup 1 ve Grup 2’nin Drenden Kan Kaybı ortalamalarından istatistiksel olarak anlamlı derecede düşük bulunmuş (p=0,001). Hiçbir grupta ameliyat sonrası enfeksiyon, DVT ve PE görülmemiştir. Sonuç: Bu çalışma primer tektaraflı TDA'da intraartiküler ve intravenöz traneksamik asidin kullanılmasının postoperatif kan kaybını anlamlı derecede azalttığını ve bunun sonucu olarak advers olaylarda, özellikle tromboembolik olaylarda bir artış olmadan kan transfüzyonu ihtiyacını azalttığını göstermiştir.

🔖

Cite This Article

KARADUMAN, Z. O. (2022). Decreased Blood Loss with Systemic and Intraarticular Tranexamic Acid Administration after Total Knee Arthroplasty. KONURALP TIP DERGİSİ, Cilt: 12 - Sayı: 1, 12–18. https://ajindex.com/articles/575537

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Tille E, Mysliwietz J, Beyer F, Postler A, Lützner J. Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty. BMC Musculoskelet Disord 2019;27;20(1):341. doi:10.1186/s12891-019-2715-9
  2. Kalairajah Y, Simpson D, Cossey AJ, Verrall GM, Spriggins AJ. Blood loss after total knee replacement: effects of computer-assisted surgery. J Bone Joint Surg Br 2005;87(11):1480-2
  3. Bidolegui F, Arce G, Lugones A, Pereira S, Vindver G. Tranexamic Acid Reduces Blood Loss and Transfusion in Patients Undergoing Total Knee Arthroplasty without Tourniquet: A Prospective Randomized Controlled Trial. Open Orthop J 2014;8:250–254. doi:10.2174/1874325001408010250
  4. Hart A, Khalil JA, Carli A, Huk O, Zukor D, Antoniou J. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am 2014;3;96(23):1945-51. doi:10.2106/JBJS.N.00077
  5. Xiong H, Liu Y, Zeng Y, Wu Y, Shen B. The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord 2018;7;19(1):321. doi: 10.1186/s12891-018-2181-9
  6. Georgiev GP, Tanchev PP, Zheleva Z, Kinov P. Comparison of topical and intravenous administration of tranexamic acid for blood loss control during total joint replacement: Review of literature. J Orthop Translat 2018;20;13:7-12. doi: 10.1016/j.jot.2017.12.006
  7. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999;57(6):1005-32
  8. Hamlin BR, DiGioia AM, Plakseychuk AY, Levison TJ. Topical versus intravenous tranexamic acid in total knee arthroplasty. J Arthroplasty 2015;30(3):384-6. doi: 10.1016/j.arth.2014.10.007
  9. Chen TP, Chen YM, Jiao JB, Wang YF, Qian LG, Guo Z, Ma Z, Han CY, Shi TH. Comparison of the effectiveness and safety of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. J Orthop Surg Res 2017;19;12(1):11. doi:10.1186/s13018-017- 0512-4
  10. Aguilera X, Martínez-Zapata MJ, Hinarejos P, Jordán M, Leal J, González JC, Monllau JC, Celaya F, Rodríguez-Arias A, Fernández JA, Pelfort X, Puig-Verdie Ll. Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch Orthop Trauma Surg